UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 141

Sortiert nach

The importance of motivation in selecting undergraduate medical students for extracurricular research programmes

PloS one, 2021-11, Vol.16 (11), p.e0260193-e0260193

2021

Volltextzugriff (PDF)

MC1R variants as melanoma risk factors independent of at-risk phenotypic characteristics: a pooled analysis from the M-SKIP project

Cancer management and research, 2018-01, Vol.10, p.1143-1154

2018

Volltextzugriff (PDF)

Multigene panel sequencing of established and candidate melanoma susceptibility genes in a large cohort of Dutch non‐CDKN2A/CDK4 melanoma families

International journal of cancer, 2019-05, Vol.144 (10), p.2453-2464

2019

Volltextzugriff (PDF)

Interplay between TERT promoter mutations and methylation culminates in chromatin accessibility and TERT expression

PloS one, 2020-04, Vol.15 (4), p.e0231418-e0231418

2020

Volltextzugriff (PDF)

Magnetic Resonance Imaging Surveillance Detects Early-Stage Pancreatic Cancer in Carriers of a p16-Leiden Mutation

Gastroenterology (New York, N.Y. 1943), 2011-03, Vol.140 (3), p.850-856

2011

Volltextzugriff (PDF)

Loss of Wild-Type CDKN2A Is an Early Event in the Development of Melanoma in FAMMM Syndrome

Journal of investigative dermatology, 2020-11, Vol.140 (11), p.2298-2301.e3

2020

Volltextzugriff (PDF)

Nonsense mutations in the shelterin complex genes ACD and TERF2IP in familial melanoma

JNCI : Journal of the National Cancer Institute, 2015-02, Vol.107 (2), p.1

2015

Volltextzugriff (PDF)

The absence of multiple atypical nevi in germline CDKN2A mutations: Comment on “Hereditary melanoma: Update on syndromes and management: Genetics of familial atypical multiple mole melanoma syndrome”

Journal of the American Academy of Dermatology, 2016-10, Vol.75 (4), p.e157-e157

2016

Volltextzugriff (PDF)

Promoter CpG Island Hypermethylation in Dysplastic Nevus and Melanoma: CLDN11 as an Epigenetic Biomarker for Malignancy

Journal of investigative dermatology, 2014-12, Vol.134 (12), p.2957-2966

2014

Volltextzugriff (PDF)

Increased Risk of Cancer Other Than Melanoma in CDKN2A Founder Mutation (p16-Leiden)-Positive Melanoma Families

Clinical cancer research, 2008-11, Vol.14 (21), p.7151-7157

2008

Volltextzugriff (PDF)

Association between a 46-SNP Polygenic Risk Score and melanoma risk in Dutch patients with familial melanoma

Journal of medical genetics, 2021-11, Vol.58 (11), p.760

2021

Volltextzugriff (PDF)

Sun exposure and melanoma risk at different latitudes: a pooled analysis of 5700 cases and 7216 controls

International journal of epidemiology, 2009-06, Vol.38 (3), p.814-830

2009

Volltextzugriff (PDF)

Accurate Quantification of T Cells in Copy Number Stable and Unstable DNA Samples Using Multiplex Digital PCR

The Journal of molecular diagnostics : JMD, 2022-01, Vol.24 (1), p.88-100

2022

Volltextzugriff (PDF)

Histologic features of melanoma associated with CDKN2A genotype

Journal of the American Academy of Dermatology, 2015-03, Vol.72 (3), p.496-507.e7

2015

Volltextzugriff (PDF)

Melanocortin 1 Receptor Function: Shifting Gears from Determining Skin and Nevus Phenotype to Fetal Growth

Journal of investigative dermatology, 2012-08, Vol.132 (8), p.1953-1955

2012

Volltextzugriff (PDF)

CM-Score: a validated scoring system to predict CDKN2A germline mutations in melanoma families from Northern Europe

Journal of medical genetics, 2018-10, Vol.55 (10), p.661

2018

Volltextzugriff (PDF)

Clinical and histologic characteristics of malignant melanoma in families with a germline mutation in CDKN2A

Journal of the American Academy of Dermatology, 2011-08, Vol.65 (2), p.281-288

2011

Volltextzugriff (PDF)

Association of HERV-K and LINE-1 hypomethylation with reduced disease-free survival in melanoma patients

Epigenomics, 2020-10, Vol.12 (19), p.1689-1706

2020

Volltextzugriff (PDF)

Predictors of Sun Protection Behaviors and Severe Sunburn in an International Online Study

Cancer epidemiology, biomarkers & prevention, 2010-09, Vol.19 (9), p.2199-2210

2010

Volltextzugriff (PDF)

Prognostic Significance of Promoter Hypermethylation and Diminished Gene Expression of SYNPO2 in Melanoma

Journal of investigative dermatology, 2015-09, Vol.135 (9), p.2328-2331

2015

Volltextzugriff (PDF)

Germline TERT promoter mutations are rare in familial melanoma

Familial cancer, 2016-01, Vol.15 (1), p.139-144

2016

Volltextzugriff (PDF)

Genome‐wide promoter methylation analysis identifies epigenetic silencing of MAPK13 in primary cutaneous melanoma

Pigment cell and melanoma research, 2013-07, Vol.26 (4), p.542-554

2013

Volltextzugriff (PDF)

Genomic analysis and clinical management of adolescent cutaneous melanoma

Pigment cell and melanoma research, 2017-05, Vol.30 (3), p.307-316

2017

Volltextzugriff (PDF)

Development and validation of a melanoma risk score based on pooled data from 16 case-control studies

Cancer epidemiology, biomarkers & prevention, 2015-05, Vol.24 (5), p.817-824

2015

Volltextzugriff (PDF)

1 – 25 von 141

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(139)
Mit Volltextzugriff
(126)

Publikationsform

Artikel
(141)

Sprache

Englisch
(141)
Japanisch
(11)

Erscheinungsjahr

n.n

Thema

Science & Technology
(109)
Humans
(104)
Life Sciences & Biomedicine
(102)
Melanoma - Genetics
(76)
Dermatology
(60)
Male
(57)
Female
(56)
Melanoma
(52)
Skin Neoplasms - Genetics
(51)
Biological And Medical Sciences
(49)
Medical Sciences
(48)
Adult
(43)
Middle Aged
(40)
Oncology
(40)
Genetic Predisposition To Disease
(33)
Aged
(32)
Medicin Och Hälsovetenskap
(30)
Tumors Of The Skin And Soft Tissue. Premalignant Lesions
(30)
Genetics & Heredity
(26)
Mutation
(26)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The importance of motivation in selecting undergraduate medical students for extracurricular research programmes

MC1R variants as melanoma risk factors independent of at-risk phenotypic characteristics: a pooled analysis from the M-SKIP project

POT1 loss-of-function variants predispose to familial melanoma

Multigene panel sequencing of established and candidate melanoma susceptibility genes in a large cohort of Dutch non‐CDKN2A/CDK4 melanoma families

Interplay between TERT promoter mutations and methylation culminates in chromatin accessibility and TERT expression

Magnetic Resonance Imaging Surveillance Detects Early-Stage Pancreatic Cancer in Carriers of a p16-Leiden Mutation

Loss of Wild-Type CDKN2A Is an Early Event in the Development of Melanoma in FAMMM Syndrome

Nonsense mutations in the shelterin complex genes ACD and TERF2IP in familial melanoma

The absence of multiple atypical nevi in germline CDKN2A mutations: Comment on “Hereditary melanoma: Update on syndromes and management: Genetics of familial atypical multiple mole melanoma syndrome”

Promoter CpG Island Hypermethylation in Dysplastic Nevus and Melanoma: CLDN11 as an Epigenetic Biomarker for Malignancy

Increased Risk of Cancer Other Than Melanoma in CDKN2A Founder Mutation (p16-Leiden)-Positive Melanoma Families

Association between a 46-SNP Polygenic Risk Score and melanoma risk in Dutch patients with familial melanoma

Sun exposure and melanoma risk at different latitudes: a pooled analysis of 5700 cases and 7216 controls

Accurate Quantification of T Cells in Copy Number Stable and Unstable DNA Samples Using Multiplex Digital PCR

Histologic features of melanoma associated with CDKN2A genotype

Melanocortin 1 Receptor Function: Shifting Gears from Determining Skin and Nevus Phenotype to Fetal Growth

CM-Score: a validated scoring system to predict CDKN2A germline mutations in melanoma families from Northern Europe

Clinical and histologic characteristics of malignant melanoma in families with a germline mutation in CDKN2A

Association of HERV-K and LINE-1 hypomethylation with reduced disease-free survival in melanoma patients

Predictors of Sun Protection Behaviors and Severe Sunburn in an International Online Study

Prognostic Significance of Promoter Hypermethylation and Diminished Gene Expression of SYNPO2 in Melanoma

Germline TERT promoter mutations are rare in familial melanoma

Genome‐wide promoter methylation analysis identifies epigenetic silencing of MAPK13 in primary cutaneous melanoma

Genomic analysis and clinical management of adolescent cutaneous melanoma

Development and validation of a melanoma risk score based on pooled data from 16 case-control studies

Suchergebnisse filtern